The relationship between tumour CD4+ T-lymphocytic infiltration and cancer-specific survival is the opposite of that previously reported for both renal and prostate cancer (Bromwich et al, 2003; McArdle et al, 2004a). This evidence concerns the gene CD4 and prostate cancer.